OUR PRODUCTS

MOBILE APPS

GENERAL INFO

LUCD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Lucid Diagnostics (LUCD) Earnings Date & Reports

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LUCD is expected to report earnings to rise 14.00% to -11 cents per share on November 17

Lucid Diagnostics LUCD Stock Earnings Reports

Q3'25

Est.

$-0.11

Q2'25

Beat

by $0.01

Q1'25

Beat

by $0.03

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.01

The last earnings report on August 13 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 759.32K shares outstanding, the current market capitalization sits at 103.93M.

View a ticker or compare two or three

Compare

LUCD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LUCD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LUCD showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry MedicalNursingServices

Profile

Fundamentals

Details

Industry

N/A

Address

360 Madison Avenue

Phone

+1 917 813-1828

Employees

Web

https://www.luciddx.com